SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-026782
Filing Date
2021-04-15
Accepted
2021-04-15 09:03:34
Documents
1
Period of Report
2021-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3890
  Complete submission text file 0001209191-21-026782.txt   5395
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address
Virani Shafique (Reporting) CIK: 0001856081 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40323 | Film No.: 21827450